Kett
Alexander Kett, Luhe-Wildenau DE
Patent application number | Description | Published |
---|---|---|
20160134093 | DEVICE FOR ESTABLISHING ELECTRICAL CONTACT BETWEEN A SHIELD OF AN ELECTRICAL CABLE AND A HOUSING, AND A PRE-ASSEMBLED CABLE - In order to ensure a reliable connection between a shield of a high-voltage cable and a housing, in particular for an electric or hybrid vehicle, the shield of the cable is crimped between an under-sleeve and a contact sleeve, forming an electrically conductive connection with the housing via the contact sleeve. The contact sleeve, formed as a crimp sleeve, also has a rim made of spring tongues. In addition, the under-sleeve is also simultaneously crimped with a cable sheathing of the cable in order to create a strain relief. Furthermore, the cable can be preferably fixed to the housing by a simple plug-locking connection. | 05-12-2016 |
20160134096 | ELECTRICAL POWER DISTRIBUTOR FOR AN ELECTRIC OR HYBRID VEHICLE - A high-voltage power distributor is configured to keep the need for high-voltage supply lines as low as possible for an electric or hybrid vehicle having an electric-motor driving motor. The high-voltage power distributor has a distributor housing formed with a connection space. At least one incoming supply line and two outgoing supply lines, which are connected to each other, are introduced into the connection space. The distributor housing has a two-part construction, with an electrically conductive inner housing and an insulating outer housing. Each respective shield of a respective supply line is connected to the inner housing in an electrically conductive manner. Thus, a mechanically robust design is enabled together with good EMC shielding in the connection region of the supply lines, and furthermore reliable sealing with respect to the environment is enabled. | 05-12-2016 |
Juergen Kett, Friedrichshafen DE
Patent application number | Description | Published |
---|---|---|
20100019741 | CIRCUIT ARRANGEMENT AND METHOD FOR REGULATING THE CURRENT IN AN ON-BOARD ELECTRICAL POWER SUPPLY SYSTEM OF A VEHICLE - A circuit arrangement for regulating the current in an on-board electric power supply system of a vehicle, with a controllable damping resistance, an energy accumulator and an electronic control unit. The damping resistance is adjustable to satisfy a control condition, such that generator current flowing through the control unit can be compensated by a counter-current originating from the energy accumulator and flowing through the damping resistance, having regard to a specified current limit value. In a method for controlling the circuit arrangement, generator current flowing through the control unit is compensated by a counter-current originating from the energy accumulator and flowing through the damping resistance, and the damping resistance is controlled, in such a manner, that a predetermined current limit value is taken into account. | 01-28-2010 |
20110004348 | ARRANGEMENT FOR TRANSMITTING DATA AND/OR SIGNALS IN A TRANSMISSION - An arrangement for transmitting data and/or signals between a transmission control device ( | 01-06-2011 |
20140049866 | Method for Controlling a Transistor and Control Circuit - A description is given of a method for the pulsed control of a transistor which has a control terminal and a load path. The load path of the transistor is connected in series with a load. A control circuit is provided for a transistor. In the method, the transistor is controlled with a control pulse of a first type, which has a first control level at least for a first time duration, before a control pulse of a second type, which has a second control level, which is higher in comparison with the first control level. A voltage across the load path of the transistor is evaluated and the pulsed control is terminated if the voltage across the load path exceeds a predefined threshold value. | 02-20-2014 |
Juergen Kett, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20130234665 | METHOD FOR CHARGING A TRACTION BATTERY - A method of charging a traction battery, in particular of a motor vehicle, from an external AC power supply system, in particular a three-phase power supply system. The traction battery to be charged is coupled, via an inverter, to an electric alternating-field machine in such manner that the AC power supply can be connected to the phase windings of the alternating-field machine. During a first step, the rotational speed of the alternating-field machine is synchronized with the frequency of the AC power supply, and during a second step, the AC power supply is connected to the phase windings of the alternating-field machine and the inverter, electrically coupled to the alternating-field machine, is operated as a step-up converter. | 09-12-2013 |
Jurgen Kett, Friedrichshafen DE
Patent application number | Description | Published |
---|---|---|
20090189557 | METHOD AND ARRANGEMENT FOR CONTROLLING AN ELECTRIC DRIVE - A method for controlling an electric drive is proposed, in which, in the event of a fault, a motor control unit of an electric motor implements a safety measure to change over to a secure operating condition, such that when a faulty three-phase current feed to the electric motor is detected, a fault-associated operating mode is activated. In addition, an arrangement for controlling an electric drive comprising an electric motor with a motor control unit is proposed, which implements a safety measure in the event of a fault so as to change over to a secure operating condition, such that when a faulty three-phase current feed to the electric motor is detected, the motor control unit activates a fault-associated operating mode. | 07-30-2009 |
Jurgen Kett, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20120299535 | ELECTRICAL CHARGING SYSTEM - An electrical charging system having a rectifier which is supplied with energy via an input. An inverter whose alternating voltage side is connected, via phase conductors, to windings of a rotating field machine and whose direct voltage side can be connected to an energy accumulator to be charged. A first current path section passes current, supplied by the rectifier, into the charging system via the plus terminal or pole of the rectifier and the rotating field machine to the inverter. The first current path section passes the current via phase windings of the rotating field machine, such that the first current path section comprises a first switch, which can selectively interrupt the first current path section. The charging system can operate, by the first switch and at least one phase winding in the first current path section, as a step-up and step-down converter in the direction toward an energy accumulator. | 11-29-2012 |
20120299543 | ELECTRICAL CHARGING SYSTEM - An electrical charging system for an energy accumulator of a motor vehicle. The electrical charging system comprises a supply input in a conductor system having at least one phase conductor and a neutral line for energy supply from a grid. The charging system also comprises a rotating field machine which, via its phase windings, is operably connected to a rectifier. The rectifier is provided on the other side for connection to the energy accumulator to be charged, the phase windings of the rotating field machine can be either selectively isolated and interconnected such that the charging system is designed for step-up connecter charging operation and step-down charging operation by way of at least one isolated phase winding and, in particular, all the isolated phase windings. | 11-29-2012 |
Nathan Kett, Columbia, TN US
Patent application number | Description | Published |
---|---|---|
20130084346 | INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS - The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved. | 04-04-2013 |
Nathan R. Kett, Franklin, TN US
Patent application number | Description | Published |
---|---|---|
20110212946 | Quinolone Neuropeptide S Receptor Antagonists - The present invention is directed to quinolone compounds which are antagonists of neuropeptide S receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which the neuropeptide S receptor is involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the neuropeptide S receptor is involved. | 09-01-2011 |
20130196002 | INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS - The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved. | 08-01-2013 |
20150024071 | INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS - The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved. | 01-22-2015 |
20150299227 | INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS - The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved. | 10-22-2015 |
Nathan R. Kett, Perkiomenville, PA US
Patent application number | Description | Published |
---|---|---|
20090069283 | Potassium Channel Inhibitors - The present invention relates to pyridine substituted ethanol compounds and derivatives thereof having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like. | 03-12-2009 |
20090325936 | IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES - The present invention relates to compounds represented by Formula (I) and Formula (II): (I) (II) or pharmaceutically acceptable salts thereof. The present invention also provides pharmaceutical compositions comprising the instant compounds. This invention further provides methods to treat and prevent pain, respiratory and non-respiratory diseases. | 12-31-2009 |
20100099673 | DECAHYDROQUINOLINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES - The present invention relates to compounds represented by Formula (I): and pharmaceutically acceptable salts thereof. The present invention also provides pharmaceutical compositions comprising the instant compounds. This invention further provides methods to treat and prevent pain, respiratory and non-respiratory diseases. | 04-22-2010 |
Victoria Kett, Belfast GB
Patent application number | Description | Published |
---|---|---|
20150079156 | LIPOSOMAL DELIVERY SYSTEM - The present invention is directed to a liposomal delivery system comprising defined lipid components, including dimethyldioctadecylammonium and other lipid components and a stabilizing agent, which may be used in the delivery of bioactive agents to a subject in need thereof. The liposomal delivery system of the invention provide improvements in terms of delivery and stability. Ideally, the liposomal delivery system is used as a vaccine or drug/medicament delivery system although other bioactive agents may be delivered. | 03-19-2015 |
Warren Kett, Darlington, NJ US
Patent application number | Description | Published |
---|---|---|
20090170159 | PRODUCTION OF GLYCOPROTEINS WITH REDUCED O-GLYCOSYLATION - A method is described for producing protein compositions having reduced amounts of O-linked glycosylation. The method includes producing the protein in cells cultured in the presence of an inhibitor of Pmt-mediated O-linked glycosylation and/or in the presence of one or more α-1,2-mannosidases. | 07-02-2009 |
Warren Kett, West Lebanon, NH US
Patent application number | Description | Published |
---|---|---|
20120237973 | PRODUCTION OF GLYCOPROTEINS WITH REDUCED O-GLYCOSYLATION - A method is described for producing protein compositions having reduced amounts of O-linked glycosylation. The method includes producing the protein in cells cultured in the presence of an inhibitor of Pmt-mediated O-linked glycosylation and/or in the presence of one or more α-1,2-mannosidases. | 09-20-2012 |
20120322101 | PRODUCTION OF GLYCOPROTEINS WITH REDUCED O-GLYCOSYLATION - A method is described for producing protein compositions having reduced amounts of O-linked glycosylation. The method includes producing the protein in cells cultured in the presence of an inhibitor of Pmt-mediated O-linked glycosylation and/or in the presence of one or more α-1,2-mannosidases. | 12-20-2012 |
Warren Charles Kett, Western Australia AU
Patent application number | Description | Published |
---|---|---|
20100160253 | SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES - The present invention relates generally to agents and medicinal protocols useful in the prophylaxis and/or treatment of respiratory diseases or conditions such as asthma, allergic rhinitis and chronic obstructive pulmonary disease (COPD). More particularly, the present invention relates to the use of a sulfated xylan or a derivative or homolog thereof in the treatment of respiratory diseases or conditions. | 06-24-2010 |
Warren Charles Kett, West Lebanon, NH US
Patent application number | Description | Published |
---|---|---|
20110190233 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE - The invention relates to anionic conjugates of glycosylated bacterial metabolites that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs). The invention also relates to processes for the preparation of the conjugates. Such conjugates are useful in the prophylaxis and/or treatment of disease conditions and in particular chronic disease conditions such as inflammatory (including allergic) diseases, metastatic cancers and infection by pathogenic agents including bacteria, viruses or parasites. | 08-04-2011 |
20110195025 | ANIONIC OLIGOSACCHARIDE CONJUGATES - The invention relates to anionic oligosaccharide conjugates that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs). | 08-11-2011 |
20140323422 | Anionic Conjugates of Glycosylated Bacterial Metabolite - The invention relates to anionic conjugates of glycosylated bacterial metabolites that may be used to mimic the structure and/or activity of the anionic bioactive molecules known as glycosaminoglycans (GAGs). The invention also relates to processes for the preparation of the conjugates. Such conjugates are useful in the prophylaxis and/or treatment of disease conditions and in particular chronic disease conditions such as inflammatory (including allergic) diseases, metastatic cancers and infection by pathogenic agents including bacteria, viruses or parasites. | 10-30-2014 |